240 related articles for article (PubMed ID: 34386069)
1. Application of natural killer cells in pancreatic cancer.
Peng X; Chen L; Jiao Y; Wang Y; Hao Z; Zhan X
Oncol Lett; 2021 Sep; 22(3):647. PubMed ID: 34386069
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.
Kumar V; Mahato RI
Cancer Lett; 2023 Nov; 579():216462. PubMed ID: 37924937
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z
Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721
[TBL] [Abstract][Full Text] [Related]
4. Current progress in cancer immunotherapy based on natural killer cells.
Bagheri Y; Barati A; Aghebati-Maleki A; Aghebati-Maleki L; Yousefi M
Cell Biol Int; 2021 Jan; 45(1):2-17. PubMed ID: 32910474
[TBL] [Abstract][Full Text] [Related]
5. Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.
Zhao X; Cai L; Hu Y; Wang H
Front Immunol; 2020; 11():584099. PubMed ID: 33193399
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of natural killer cells for cancer immunotherapy.
Miyazato K; Hayakawa Y
Cancer Sci; 2020 Jun; 111(6):1869-1875. PubMed ID: 32301190
[TBL] [Abstract][Full Text] [Related]
7. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
8. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy.
Zhang J; Zheng H; Diao Y
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646574
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
11. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
12. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
Lin C; Zhang J
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.
Van Audenaerde JRM; Roeyen G; Darcy PK; Kershaw MH; Peeters M; Smits ELJ
Pharmacol Ther; 2018 Sep; 189():31-44. PubMed ID: 29660367
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
15. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
16. The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.
Rezvani K; Rouce RH
Front Immunol; 2015; 6():578. PubMed ID: 26635792
[TBL] [Abstract][Full Text] [Related]
17. NK Cell-Based Immunotherapy in Cancer Metastasis.
Lorenzo-Herrero S; López-Soto A; Sordo-Bahamonde C; Gonzalez-Rodriguez AP; Vitale M; Gonzalez S
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30597841
[TBL] [Abstract][Full Text] [Related]
18. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
19. Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.
Phung CD; Tran TH; Kim JO
Arch Pharm Res; 2020 Jan; 43(1):32-45. PubMed ID: 31993969
[TBL] [Abstract][Full Text] [Related]
20. Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
Pierce S; Geanes ES; Bradley T
Front Cell Infect Microbiol; 2020; 10():231. PubMed ID: 32509600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
